Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Updated on: August 27,2024

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Updated on:August 27,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on: March 30,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on:March 30,2024

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working

Updated on: September 07,2024

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working

Updated on:September 07,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on: March 12,2024

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

Updated on:March 12,2024

Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval

by Bradley J. FikesCancer cell during cell division. Credit: National Institutes of HealthA promising cancer drug, discovered in San Diego and later discarded for safety concerns, has at last been app

Updated on: April 22,2024

Once shelved as too risky, blood cancer drug discovered in San Diego gets FDA approval

by Bradley J. FikesCancer cell during cell division. Credit: National Institutes of HealthA promising cancer drug, discovered in San Diego and later discarded for safety concerns, has at last been app

Updated on:April 22,2024

Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

byThe Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainImmunotherapy after surgery increased bladder cancer patients' chance of staying cancer-free compared to patients who received a p

Updated on: January 04,2024

Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

byThe Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainImmunotherapy after surgery increased bladder cancer patients' chance of staying cancer-free compared to patients who received a p

Updated on:January 04,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on: April 18,2024

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth

Updated on:April 18,2024

Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

by University of TorontoCredit: Pixabay/CC0 Public DomainAlthough genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mu

Updated on: February 01,2024

Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation

by University of TorontoCredit: Pixabay/CC0 Public DomainAlthough genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mu

Updated on:February 01,2024

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme

Updated on: January 07,2024

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme

Updated on:January 07,2024

New lease on life for two lung cancer patients after pioneering double-lung transplant

by Cara MurezRetired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care.But Ameli, of Minneapolis, had other ideas. S

Updated on: December 28,2023

New lease on life for two lung cancer patients after pioneering double-lung transplant

by Cara MurezRetired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care.But Ameli, of Minneapolis, had other ideas. S

Updated on:December 28,2023

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on: January 30,2024

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on:January 30,2024

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n

Updated on: January 25,2024

Study: Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma

byH. Lee Moffitt Cancer Center & Research InstituteProposed mechanism of the two ICI combinations. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit:&n

Updated on:January 25,2024